(2024), intravesicular (bladder) injections of BPC-157 were reported to result in 80100% resolution of moderate to severe interstitial cystitis at 6 weeks post- treatment
The perfusion needle was placed near the eye with a perfusion rate of 0.3 ml/min
Unlike retinoids, copper peptides have no known mechanism for fetal harm, and many dermatologists consider them a reasonable alternative
Baseline and interval laboratory monitoring should include: fasting glucose and HbA1c (tirzepatide can cause hypoglycemia in non-diabetic subjects if caloric intake drops too low), lipase and amylase (pancreatitis risk with GLP-1 agonists), liver function tests (AST, ALT, bilirubin), and thyroid panel (TSH, free T3, free T4)
Continued exploration of BPC 157s capabilities can unlock new possibilities for treating various conditions and improving patient outcomes